Articles dans des revues avec comité de lecture (260)
  1. 94. Mallet, C., Daulhac, L., Bonnefont, J., Ledent, C., Etienne, M., Chapuy, E., Libert, F., & Eschalier, A. (2008). Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia. Pain, 139(1), 190-200. doi:10.1016/j.pain.2008.03.030
  2. 95. Gray, K. T., Short, J. L., Ledent, C., & Ventura, S. (2008). Targeted disruption of the A2A adenosine receptor reduces in-vitro prostate contractility in mature mice. European journal of pharmacology, 592(1-3), 151-157. doi:10.1016/j.ejphar.2008.07.003
  3. 96. Suárez, J., Bermúdez-Silva, F. J., Mackie, K., Ledent, C., Zimmer, A., Cravatt, B. F., & de Fonseca, F. R. (2008). Immunohistochemical description of the endogenous cannabinoid system in the rat cerebellum and functionally related nuclei. Journal of comparative neurology, 509(4), 400-421. doi:10.1002/cne.21774
  4. 97. El Yacoubi, M., Ledent, C., Parmentier, M., Costentin, J., & Vaugeois, J.-M. (2008). Evidence for the involvement of the adenosine A(2A) receptor in the lowered susceptibility to pentylenetetrazol-induced seizures produced in mice by long-term treatment with caffeine. Neuropharmacology, 55(1), 35-40. doi:10.1016/j.neuropharm.2008.04.007
  5. 98. Touriño, C., Ledent, C., Maldonado, R., & Valverde, O. (2008). CB1 cannabinoid receptor modulates 3,4-methylenedioxymethamphetamine acute responses and reinforcement. Biological psychiatry, 63(11), 1030-1038. doi:10.1016/j.biopsych.2007.09.003
  6. 99. Ben Addi, A., Lefort, A., Hua, X., Libert, F., Communi, D., Ledent, C., Macours, P., Tilley, S. L., Boeynaems, J.-M., & Robaye, B. (2008). Modulation of murine dendritic cell function by adenine nucleotides and adenosine: involvement of the A(2B) receptor. European Journal of Immunology, 38(6), 1610-1620. doi:10.1002/eji.200737781
  7. 100. Teng, B., Ledent, C., & Mustafa, S. J. (2008). Up-regulation of A 2B adenosine receptor in A 2A adenosine receptor knockout mouse coronary artery. Journal of Molecular and Cellular Cardiology, 44(5), 905-914. doi:10.1016/j.yjmcc.2008.03.003
  8. 101. Ribé, D., Sawbridge, D., Thakur, S., Hussey, M., Ledent, C., Kitchen, I., Hourani, S., & Li, J.-M. (2008). Adenosine A2A receptor signaling regulation of cardiac NADPH oxidase activity. Free radical biology & medicine, 44(7), 1433-1442. doi:10.1016/j.freeradbiomed.2007.12.035
  9. 102. Aso, E., Ozaita, A., Valdizán, E. M., Ledent, C., Pazos, A., Maldonado, R., & Valverde, O. (2008). BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice. Journal of neurochemistry, 105(2), 565-572. doi:10.1111/j.1471-4159.2007.05149.x
  10. 103. Németh, B., Ledent, C., Freund, T. F., & Hájos, N. (2008). CB1 receptor-dependent and -independent inhibition of excitatory postsynaptic currents in the hippocampus by WIN 55,212-2. Neuropharmacology, 54(1), 51-57. doi:10.1016/j.neuropharm.2007.07.003
  11. 104. Balázsa, T., Bíró, J., Gullai, N., Ledent, C., & Sperlágh, B. (2008). CB1-cannabinoid receptors are involved in the modulation of non-synaptic [3H]serotonin release from the rat hippocampus. Neurochemistry international, 52(1-2), 95-102. doi:10.1016/j.neuint.2007.07.008
  12. 105. Croxford, J. L., Pryce, G., Jackson, S. J., Ledent, C., Giovannoni, G., Pertwee, R. G., Yamamura, T., & Baker, D. (2008). Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis. Journal of neuroimmunology, 193(1-2), 120-129. doi:10.1016/j.jneuroim.2007.10.024
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 Suivant >>